Study Comparing GDC 695 and Diclofenac Sodium Gel, 3% in Subjects With Actinic Keratoses

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This research study is being done to compare the safety and effectiveness of GDC 695 (test drug) against the currently marketed reference drug (diclofenac sodium gel, 3%) and to establish that these two drugs work better than placebo in the treatment of actinic keratosis.
Epistemonikos ID: 6a542c9af9976611d91bb0b76aa07bb2e484be97
First added on: May 17, 2024